StreetInsider.com News Articles

IMPLANET Reports First-Half 2026 Results

Tue, 15 Sep 2026 11:45:00 -0400

First-half revenue up +23% to €7.1 million
Operating income improved by 13%

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:

IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and in the distribution of advanced medical equipment, today announces its results for the first half of the current financial year, ended June 30, 2026, as approved by the Board of Directors on September 15, 2026.

Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “The sustained growth in our business during the first half of the year was accompanied by a significant improvement in

IMPLANET Reports First-Half 2026 Results

Tue, 15 Sep 2026 11:45:00 -0400

First-half revenue up +23% to €7.1 million

Operating income improved by 13%

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and in the distribution of advanced medical equipment, today announces its results for the first half of the current financial year, ended June 30, 2026, as approved by the Board of Directors on September 15, 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “The sustained growth in our business during the first half of the year was accompanied by a significant improvement in

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Announces the Installation of the 8i Robotics Solution at Amiens-Picardie University Hospital

Wed, 15 Jul 2026 12:00:00 -0400

Preclinical evaluation of the world's first multi-arm surgical robot

In collaboration with the hospital-university teams of the GRECO Robotic Surgery Research Group at the University of Picardie Jules Verne, the SimUSanté® Active Learning Simulation Center, and the GRECO EXPER experimentation platform

BORDEAUX, France & MEMPHIS, Tenn.--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for the PEA-PME scheme), a medical technology company specializing in spinal implants for orthopedic surgery and the distribution of advanced medical equipment, today announces the installation of 8i Robotics Inc.'s multi-arm surgical robot at Amiens-Picardie University Hospital, within the SimUSanté® Active Learning Simulation Center.
The

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the

IMPLANET Reports First-Half 2026 Revenue of €7.1 Million, up +23%

Tue, 07 Jul 2026 11:45:00 -0400

Q2 2026 revenue up +27% to €4.1 million

8th consecutive quarter of sustained growth

Balanced growth across both Spine Implants and Medical Equipment businesses in the first half of 2026, with sales of the new JSS hybrid posterior fixation system doubling

BORDEAUX, France & BOSTON--(BUSINESS WIRE)-- Regulatory News:
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announces its revenue for the first half of 2026.
Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: “With a second quarter marked by sustained growth, the